Your trusted source for investing success

Tag: united states

Energy Fuels and Ur-Energy Jointly File Section 232 Petition with U.S. Commerce Department to Investigate Effects of Uranium Imports on U.S. National Security

Energy Fuels and Ur-Energy Jointly File Section 232 Petition with U.S. Commerce Department to Investigate Effects of Uranium Imports on U.S. National Security

Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels”) and Ur-Energy Inc. (NYSE American: URG; TSX: URE) (“Ur-Energy”) today jointly submitted a Petition to the U.S. Department of Commerce (“DOC”) for Relief Under Section 232 of the Trade Expansion Act of 1962 (as amended) from Imports of Uranium Products

NovoHeart Files Patent Application on Three-Tier Drug Screening System

Novoheart (TSXV:NVH) announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO for a three-tiered drug screening system with enhanced capability, sensitivity and accuracy for detecting pharmacological effects on heart contractility that cannot be achieved with conventional models.

As quoted in the press

Pediapharm Begins Trading on the OTCQB Venture Market

Pediapharm (TSXV:PDP) is pleased to announce the Company’s common shares begin trading today on the OTCQB Venture Market in the United States under the symbol “PDDPF”.

As quoted in the press release:
“Getting listed on the OTCQB is part of our strategy to introduce Pediapharm to a wider audience,” stated Sylvain Chretien,

Trilogy Metals Reports Significant Copper and Zinc Drill Result for the Arctic Deposit and Plans for an Ore Sorting Study

Trilogy Metals Inc. (TSX/NYSE American: TMQ) (“Trilogy Metals” or the “Company”) is pleased to announce additional in-fill drill results and provide a project update from its 2017 summer field program at the Arctic poly-metallic volcanogenic massive sulphide (“VMS”) deposit, part of the Upper Kobuk Mineral Projects (“UKMP”) located in the Ambler mining

Nuvo Subsidiary Obtains Rights to Resultz

Nuvo Pharmaceuticals (TSX:NRI; OTCQX:NRIFF) announced its Ireline subsidiary acquired the U.S. rights of Resultz from Piedmont Pharmaceuticals.

As quoted in the press release:
The acquisition includes all U.S. product and intellectual property rights and is a complementary follow-on to Nuvo’s acquisition of the global, ex-U.S. Resultz product rights announced on January 2, 2018.  Nuvo now owns

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
American CuMo Mining Provides Update to Shareholders

URL: https://investingnews.com/daily/resource-investing/precious-metals-investing/silver-investing/american-cumo-mining-provides-update-shareholders/